New cell therapy SUPLEXA shows promise in early cancer trial
NCT ID NCT05237206
First seen Sep 30, 2025 · Last updated May 12, 2026 · Updated 23 times
Summary
This early study tested a new treatment called SUPLEXA in 46 adults with advanced solid tumors or blood cancers that had spread. The main goal was to see if the treatment is safe and tolerable. Patients received repeated infusions of SUPLEXA cells, and researchers monitored side effects and any signs that the tumors shrank or changed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Research Sa (Crsa)
Adelaide, South Australia, 5000, Australia
-
Greenslopes Private Hospital/Gallipoli Medical Research Foundation
Brisbane, Queeensland, 4120, Australia
-
Southern Oncology Clinical Research Unit (SOCRU)
Adelaide, South Australia, 5042, Australia
Conditions
Explore the condition pages connected to this study.